This article was previously published in RadMag.
From the 25th to 29th April the Brighton Conference Centre hosted the British Nuclear Medicine Society Annual Scientific Meeting. The four-day format kicks off with Bootcamp on the Sunday afternoon. The Bootcamp focus this year on PET/CT in Oncology with parallel clinical and technologist streams drew a diverse crowd and truly had something for everyone.
Considering taking a career in Nuclear Medicine?
Now is the time to visit RCP's website featuring Nuclear Medicine as specialty of the month.
The Royal College of Physicians talk to some of our members of the BNMS about the speciality, why they chose nuclear medicine, what the training is like and why trainees should choose it as a career.
As we all know, molecular radiotherapy (MRT) is a highly multidisciplinary area, or at least should be if safe and effective treatment is intended. Nuclear Medicine is at the heart of MRT with expertise in radiochemistry, imaging and physics as well as clinical experience. This is a rapidly expanding area and the BNMS are maintaining a high profile in the field.
ARSAC – Triennial Review
During Autumn 2014 the Department of Health (DH) is undertaking a triennial review of the Administration of Radioactive Substances Advisory Committee (ARSAC). This forms part of a wider programme of reviews taking place of all the Department’s Arm’s Length Bodies in support of the Department’s stewardship function in the new health and social care system, and will support the government wide agenda on reform of public bodies.
An important part of the review process is the gathering of evidence from ARSAC's key stakeholders through a Call for Evidence seeking views on:
1. The continuing need for ARSAC in terms of the functions it performs and how these are delivered
2. ARSAC's performance and opportunities for efficiencies
This is an open call for evidence, and DH is interested in receiving responses from all interested parties.
The Call for Evidence will be published in mid-November on the public consultations section of www.gov.uk<http://www.gov.uk>:
If you are have questions which are not answers on in the call for evidence documentation please contact the lead reviewer, Adam McMordie, at the Department of Health at. email@example.com<mailto:firstname.lastname@example.org>”
THE BRITISH INSTITUTE OF RADIOLOGY (BIR) LAUNCHES NEW OPEN ACCESS JOURNAL
Alliance Medical, has secured a deal to become the exclusive UK distributor of IBA’s SPECT radiopharmaceuticals (including Mo-99 generators) as part of their goal to provide a secure supply of radionuclides / radiopharmaceuticals to UK patients and the UK diagnostic imaging market.
Full Announcement HERE